What is it about?
People living with hepatitis C virus have a high risk of developping metabolic disorders such as diabetes. Those disorders and their accumulation constitute risk factors for liver disease progression. Some of those risks may persist after hepatitis C virus cure. We found that people with hepatitis C virus who used cannabis had lower risks of having diabetes, obesity, and hypertension.
Featured Image
Photo by Inspector CBD on Unsplash
Why is it important?
Cannabis or cannabinoids may have clinical utility for the management of metabolic disorders.
Perspectives
More cannabinoid‐based research is needed in order to understand the mechanisms involved in metabolic regulation by cannabinoids and to develop safe therapeutics.
Tangui Barré
Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France
Read the Original
This page is a summary of: Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort), Journal of Clinical Medicine, October 2022, MDPI AG,
DOI: 10.3390/jcm11206135.
You can read the full text:
Contributors
The following have contributed to this page
